CIK 0001665988 · Accelerated filer<br>Emerging growth company
Bioventus Inc.
Sign in to watch- Ticker
- BVS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 810980861
- Phone
- (919) 474-6700
- Business address
- 4721 EMPEROR BOULEVARD, SUITE 100, DURHAM, NC, 27703
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 23 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-04-01 | Cowdy Philip G. Director | Option exercise | +2,700 | 11,700 | ||
| 2022-04-01 | Cowdy Philip G. Director | Option exercise · Restricted Stock Units | −2,700 | 0 | ||
| 2022-04-01 | NOHRA GUY P Director | Option exercise | +2,700 | 11,700 | ||
| 2022-04-01 | NOHRA GUY P Director | Option exercise · Restricted Stock Units | −2,700 | 0 | ||
| 2022-04-01 | NEELS GUIDO J Director | Option exercise | +2,700 | 11,700 | ||
| 2022-04-01 | NEELS GUIDO J Director | Option exercise · Restricted Stock Units | −2,700 | 0 | ||
| 2022-04-01 | Pavesio Alessandra SVP & Chief Science Officer | Option exercise | +61,476 | 181,306 | ||
| 2022-04-01 | Pavesio Alessandra SVP & Chief Science Officer | Option exercise · Restricted Stock Units | −61,476 | 0 | ||
| 2022-04-01 | STALNECKER SUSAN M Director | Option exercise | +23,416 | 32,416 | ||
| 2022-04-01 | STALNECKER SUSAN M Director | Option exercise · Restricted Stock Units | −23,416 | 0 | ||
| 2022-04-01 | SUTTER MARTIN P Director | Option exercise | +2,700 | 11,700 | ||
| 2022-04-01 | SUTTER MARTIN P Director | Option exercise · Restricted Stock Units | −2,700 | 0 | ||
| 2022-03-14 | Reali Kenneth Michael Fmr. CEO and Director | Grant or award · Stock Option (Right to Buy) | +466,054 | 466,054 | ||
| 2022-03-14 | Pavesio Alessandra Fmr. SVP & Chief Science Off. | Grant or award · Restricted Stock Units | +35,545 | 35,545 | ||
| 2022-03-14 | Pavesio Alessandra Fmr. SVP & Chief Science Off. | Grant or award · Stock Option (Right to Buy) | +96,133 | 96,133 | ||
| 2022-03-14 | D'Adamio Anthony SVP & General Counsel | Grant or award · Stock Option (Right to Buy) | +96,133 | 96,133 | ||
| 2022-03-14 | CHURCH KATRINA J SVP & Chief Compliance Officer | Grant or award · Stock Option (Right to Buy) | +37,385 | 37,385 | ||
| 2022-03-14 | D'Adamio Anthony SVP & General Counsel | Grant or award · Restricted Stock Units | +35,545 | 35,545 | ||
| 2022-03-14 | HAWKINS WILLIAM A Director | Grant or award · Restricted Stock Units | +3,949 | 3,949 | ||
| 2022-03-14 | Reali Kenneth Michael Chief Executive Officer | Grant or award · Restricted Stock Units | +114,882 | 114,882 |
Page 19 of 22 · 437 trades